Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 5
2005 4
2007 2
2008 4
2009 2
2010 4
2011 2
2012 2
2013 1
2014 6
2015 4
2016 2
2017 3
2018 3
2019 5
2020 5
2021 6
2022 6
2023 6
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
Choledocholithiasis.
Chebli JM, Gaburri PD, Morais JM. Chebli JM, et al. Lancet. 2005 Aug 27-Sep 2;366(9487):748. doi: 10.1016/S0140-6736(05)67180-2. Lancet. 2005. PMID: 16125593 No abstract available.
Ulcerative colitis - treatment with biologicals.
Teixeira FV, Vilela EG, Damião AOMC, Vieira A, Albuquerque IC, Parente JML, Chebli JMF, Ambrogini Junior O, Hossne RS, Miszputen SJ. Teixeira FV, et al. Among authors: chebli jmf. Rev Assoc Med Bras (1992). 2019 May 2;65(4):547-553. doi: 10.1590/1806-9282.65.4.547. Rev Assoc Med Bras (1992). 2019. PMID: 31066808 Free article.
Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study.
da Costa Ferreira S, Parra RS, Sassaki LY, Parente JML, de Mello MK, Chebli LA, Luporini RL, Alves Junior AJT, Firmino Nóbrega FJ, da Silva BC, Miranda EF, Quaresma AB, Nicollelli GM, Gasparini RG, Dutra RM, Vasconcelos JRO, da Silva KDC, Magro DO, Imbrizi MR, Nagasako CK, Féres O, Troncon LEA, Kotze PG, Chebli JMF. da Costa Ferreira S, et al. Among authors: chebli jmf. Gastroenterol Hepatol. 2025 Feb 21:502396. doi: 10.1016/j.gastrohep.2025.502396. Online ahead of print. Gastroenterol Hepatol. 2025. PMID: 39987969 Free article. English, Spanish.
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Baima JP, Imbrizi M, Andrade AR, Chebli LA, Argollo MC, Queiroz NSF, Azevedo MFC, Vieira A, Costa MHM, Fróes RSB, Penna FGCE, Quaresma AB, Damião AOMC, Moraes ACDS, Santos CHMD, Flores C, Zaltman C, Vilela EG, Morsoletto E, Gonçalves Filho FA, Santana GO, Zabot GP, Parente JML, Sassaki LY, Zerôncio MA, Machado MB, Cassol OS, Kotze PG, Parra RS, Miszputen SJ, Coy CSR, Ambrogini Junior O, Chebli JMF, Saad-Hossne R. Baima JP, et al. Among authors: chebli jmf. Arq Gastroenterol. 2023 Mar 24;59(suppl 1):51-84. doi: 10.1590/S0004-2803.2022005S1-03. eCollection 2023. Arq Gastroenterol. 2023. PMID: 36995889 Free article.
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Imbrizi M, Baima JP, Azevedo MFC, Andrade AR, Queiroz NSF, Chebli JMF, Chebli LA, Argollo MC, Sassaki LY, Parra RS, Quaresma AB, Vieira A, Damião AOMC, Moraes ACDS, Flores C, Zaltman C, Vilela EG, Morsoletto EM, Gonçalves Filho FA, Penna FGCE, Santana GO, Zabot GP, Parente JML, Costa MHM, Zerôncio MA, Machado MB, Cassol OS, Kotze PG, Fróes RSB, Miszputen SJ, Ambrogini Junior O, Saad-Hossne R, Coy CSR. Imbrizi M, et al. Among authors: chebli jmf. Arq Gastroenterol. 2023 Mar 24;59(suppl 1):20-50. doi: 10.1590/S0004-2803.2022005S1-02. eCollection 2023. Arq Gastroenterol. 2023. PMID: 36995888 Free article.
81 results